IRadimed Corporation
General ticker "IRMD" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.1B (TTM average)
IRadimed Corporation follows the US Stock Market performance with the rate: 38.5%.
Estimated limits based on current volatility of 2.6%: low 92.68$, high 97.57$
Factors to consider:
- Earnings expected soon, date: 2026-07-30 bmo
- Company pays dividends (quarterly): last record date 2026-05-15, amount 0.20$ (Y0.82%)
- Total employees count: 166 (+3.8%) as of 2025
- Top business risk factors: Dependence on limited products, Supply chain disruptions, IT security, Regulatory and compliance, Single facility risk
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [70.74$, 106.24$]
- 2026-12-31 to 2027-12-31 estimated range: [70.07$, 106.25$]
Financial Metrics affecting the IRMD estimates:
- Negative: with PPE of 50.4 at the end of fiscal year the price was high
- Positive: Return on assets ratio (scaled to [-100,100]) of 17.13 > 6.02
- Positive: Operating profit margin, % of 31.20 > 18.40
- Positive: Industry inventory ratio change (median), % of 0.25 <= 0.28
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -0.03 < Operating cash flow per share per price, % of 2.02
- Positive: Shareholder equity ratio, % of 86.98 > 64.23
Short-term IRMD quotes
Long-term IRMD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $65.56MM | $73.24MM | $83.81MM |
| Operating Expenses | $45.53MM | $51.28MM | $57.67MM |
| Operating Income | $20.04MM | $21.96MM | $26.15MM |
| Non-Operating Income | $1.70MM | $2.31MM | $2.21MM |
| R&D Expense | $2.86MM | $2.83MM | $2.98MM |
| Income(Loss) | $21.74MM | $24.28MM | $28.36MM |
| Taxes | $4.55MM | $5.04MM | $5.88MM |
| Net Income(Loss)* | $17.19MM | $19.23MM | $22.48MM |
| Stockholders Equity | $71.42MM | $86.82MM | $94.62MM |
| Inventory | $12.82MM | $10.40MM | $11.62MM |
| Assets | $92.16MM | $98.33MM | $108.78MM |
| Operating Cash Flow | $13.47MM | $25.62MM | $24.95MM |
| Capital expenditure | $8.01MM | $8.01MM | $7.76MM |
| Investing Cash Flow | $-8.01MM | $-8.82MM | $-8.42MM |
| Financing Cash Flow | $-13.66MM | $-14.34MM | $-17.60MM |
| Earnings Per Share** | $1.36 | $1.52 | $1.77 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.